• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

I don't know whether to be happy or sad?

anonymous

Guest
18194582_1341289245906917_4640024841277660284_n.jpg